BUND FINANCE

BUND FINANCE › Stocks › IDXX

IDEXX Laboratories, Inc. (IDXX)

NASDAQ · Stock price, chart and technical analysis

US$698.47+8.23 (+1.19%)

Data from Financial Modeling Prep · Nov 18, 2026, 4:00 PM New York time · may be delayed

Open the live chartSee Technicals⏱ Analyze entryQuarterly earnings📅 See in calendar💬 Explain this move⇄ ComparePractice in the Simulator

Key stats

Previous closeUS$690.24
OpenUS$684.64
Day rangeUS$683.72 – US$704.85
52-week rangeUS$500.61 – US$769.98
Market capUS$55.03B
Volume372,464
50-day averageUS$569.11
200-day averageUS$572.75
Beta1.54

Quick technical read

This describes price action; it is not a recommendation. The app also calculates RSI, MACD, the entry setup and 30+ indicators. How we calculate it

Fundamentals Annual

Fiscal year20212022202320242025
RevenueUS$3.2BUS$3.4BUS$3.7BUS$3.9BUS$4.3B
Net incomeUS$744.8MUS$679.1MUS$845.0MUS$887.9MUS$1.1B
EPS (diluted)8.608.0310.0610.6713.08
Gross margin58.8%59.5%59.8%61.0%61.8%
Operating margin29.0%26.7%30.0%29.0%31.6%
Net margin23.2%20.2%23.1%22.8%24.6%
Free cash flowUS$636.0MUS$394.1MUS$772.9MUS$798.1MUS$1.1B
Total debtUS$1.0BUS$1.5BUS$1.1BUS$986.9MUS$1.1B
CashUS$144.5MUS$112.5MUS$453.9MUS$288.3MUS$180.1M

Compound annual growth: revenue 7.6% · net income 9.2% (4 years).

Valuation: today, its history and its sector

Today5-year averageSector median (Healthcare)
P/E47.4x54.0x27.1x
EV / EBITDA33.4x38.4x16.5x
Operating margin32.3%—3.6%
Net margin25.4%—-0.0%
Debt / equity0.98—0.58

Source: annual financial statements from Financial Modeling Prep. “Today” uses the current price and the last 4 quarters. The sector median uses U.S. companies above US$300M market cap. A multiple above or below its history or sector is not a recommendation.

About IDEXX Laboratories, Inc.

SectorHealthcare
IndustryMedical - Diagnostics & Research
CountryUS
CEOMichael Erickson
Employees11,000
IPO date1991-06-21

IDEXX Laboratories, Inc. is a global enterprise focused on creating, producing, and distributing a wide array of products and services. Its primary client base includes companion animal veterinary practices, the livestock and poultry industries, dairy operations, and water quality testing sectors. The company organizes its operations across several key divisions: the Companion Animal Group (CAG), Water Quality Products, Livestock, Poultry, and Dairy (LPD), and additional segments. For companion animals, IDEXX offers a comprehensive suite of point-of-care veterinary diagnostic tools, such as instruments, consumables, and rapid assay kits. It also provides reference laboratory diagnostic and c…

www.idexx.com

Other stocks on BUND FINANCE

Not financial advice. BUND FINANCE publishes general information for educational purposes. Investing involves risk, including loss of capital. Legal notice